Crispr Therapeutics Ag (CRSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 943,771 | 456,649 | 239,758 | 315,520 | 155,961 |
| Receivables | 99 | 88 | 2,626 | 3,157 | 339 |
| TOTAL | $987,547 | $466,395 | $248,385 | $320,188 | $156,840 |
| Non-Current Assets | |||||
| PPE Net | 31,330 | 18,500 | 18,857 | 21,027 | 1,328 |
| Intangibles | 235 | 289 | 344 | 399 | 454 |
| Other Non-Current Assets | 47,640 | 3,832 | 3,760 | 3,348 | 801 |
| TOTAL | $79,205 | $22,621 | $22,961 | $24,774 | $2,583 |
| Total Assets | $1,066,752 | $489,016 | $271,346 | $344,962 | $159,423 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,944 | 5,069 | 1,639 | 4,569 | 1,584 |
| Accrued Expenses | 30,763 | 21,254 | 11,708 | 16,343 | 8,511 |
| Other current liabilities | 10,950 | 1,321 | 1,164 | 1,086 | 60 |
| TOTAL | $57,106 | $27,746 | $14,511 | $21,998 | $10,155 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 38,336 |
| Deferred Revenues | 960 | 102 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 58,445 | 11,295 | 12,075 | 12,497 | 770 |
| TOTAL | $70,221 | $69,075 | $69,003 | $90,118 | $113,871 |
| Total Liabilities | $127,327 | $96,821 | $83,514 | $112,116 | $124,026 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 60,846 | N/A | N/A | N/A | N/A |
| Common Shares | 1,847 | 1,584 | 1,240 | 1,216 | 181 |
| Retained earnings | -224,711 | -291,569 | -125,440 | -57,083 | -33,906 |
| Other shareholders' equity | -56 | -65 | 14 | -26 | -35 |
| TOTAL | $939,425 | $392,195 | $187,832 | $232,846 | $-29,124 |
| Total Liabilities And Equity | $1,066,752 | $489,016 | $271,346 | $344,962 | $94,902 |